Health Condition 1: N719- Inflammatory disease of uterus, unspecified Health Condition 2: N72- Inflammatory disease of cervix uteri Health Condition 3: N840- Polyp of corpus uteri Health Condition 4: N841- Polyp of cervix uteri Health Condition 5: N850- Endometrial hyperplasia Health Condition 6: N856- Intrauterine synechiae Health Condition 7: N857- Hematometra Health Condition 8: N858- Other specified noninflammatory disorders of uterus Health Condition 9: N859- Noninflammatory disorder of ute
Conditions
Interventions
Intervention1: omittance of ripening agent: omittance of tab misoprostol for cervical ripening prior to hysteroscopic procedures in perimenopausal patients
Sponsors
self
Eligibility
Inclusion criteria
Inclusion criteria: premenopausal Indicated for diagnostic or Operative hysteroscopy Willing and able to provide informed consent
Exclusion criteria
Exclusion criteria: Allergy to prostaglandins Prior cervical surgery Active pelvic infection Pregnancy Anatomical abnormalities (e.g., cervical stenosis, M llerian anomalies)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the hysteroscope insertion ease in premenopausal woman undergoing hysteroscopy with or without cervical primingTimepoint: at baseline (during procedure) | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess procedure time (starting from vaginoscopy to entering the uterine cavity) To assess need for cervical dilatation in both groups Timepoint: at baseline (during procedure) | — |
Countries
India
Contacts
Public ContactDr Yogita Satpute
All India Institute of Medical Sciences, Nagpur
Outcome results
None listed